Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging
- PMID: 18493654
- PMCID: PMC2848974
- DOI: 10.1039/b720018h
Visualizing the spatial distribution of secondary metabolites produced by marine cyanobacteria and sponges via MALDI-TOF imaging
Abstract
Marine cyanobacteria and sponges are prolific sources of natural products with therapeutic applications. In this paper we introduce a mass spectrometry based approach to characterize the spatial distribution of these natural products from intact organisms of differing complexities. The natural product MALDI-TOF-imaging (npMALDI-I) approach readily identified a number of metabolites from the cyanobacteria Lyngbya majuscula 3L and JHB, Oscillatoria nigro-viridis, Lyngbya bouillonii, and a Phormidium species, even when they were present as mixtures. For example, jamaicamide B, a well established natural product from the cyanobacterium Lyngbya majuscula JHB, was readily detected as were the ions that correspond to the natural products curacin A and curazole from Lyngbya majuscula 3L. In addition to these known natural products, a large number of unknown ions co-localized with the different cyanobacteria, providing an indication that this method can be used for dereplication and drug discovery strategies. Finally, npMALDI-I was used to observe the secondary metabolites found within the sponge Dysidea herbacea. From these sponge data, more than 40 ions were shown to be co-localized, many of which were halogenated. The npMALDI-I data on the sponge indicates that, based on the differential distribution of secondary metabolites, sponges have differential chemical micro-environments within their tissues. Our data demonstrate that npMALDI-I can be used to provide spatial distribution of natural products, from single strands of cyanobacteria to the very complex marine assemblage of a sponge.
Figures
References
-
- Newman DJ, Cragg GM. Natural Products as Sources of New Drugs over the Last 25 Years. Journal of Natural Products. 2007;70(3):461–477. - PubMed
-
- Bode BH, Mueller R. The impact of bacterial genomics on natural product research. Angewandte Chemie, International Edition. 2005;44(42):6828–6846. - PubMed
-
- Dubois J, Guenard D, Gueritte F. Recent developments in antitumour taxoids. Expert Opinion on Therapeutic Patents. 2003;13(12):1809–1823.
-
- Demain AL. Pharmaceutically active secondary metabolites of microorganisms. Applied.Microbiology and Biotechnology. 1999;52:455–463. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
